Cardiovascular Manifestations in Rheumatoid Arthritis.
Sanghavi N, Ingrassia JP, Korem S, Ash J, Pan S, Wasserman A.
Cardiol Rev. 2024 Mar-Apr 01;32(2):146-152. doi: 10.1097/CRD.0000000000000486. Epub 2022 Nov 21.
Myocarditis in connective tissue diseases: an often-overlooked clinical manifestation.
Azzam M, Awad A, Abugharbyeh A, Kahaleh B.
Rheumatol Int. 2023 Nov;43(11):1983-1992. doi: 10.1007/s00296-023-05428-w. Epub 2023 Aug 16.
Autoimmune valvular carditis.
Breed ER, Binstadt BA.
Curr Allergy Asthma Rep. 2015 Jan;15(1):491. doi: 10.1007/s11882-014-0491-z.
Immune checkpoint inhibitor-induced myocarditis and multiple adverse events with pre-existing rheumatoid arthritis: a case report and literature review.
Kachi S, Shirakashi M, Nomizo T, Onishi M, Toda Kato E, Nobashi TW, Onizawa H, Hiwa R, Tsuji H, Akizuki S, Nakashima R, Onishi A, Yoshifuji H, Tanaka M, Murakami K, Morinobu A.
Immunol Med. 2025 Jun 5:1-7. doi: 10.1080/25785826.2025.2515688. Online ahead of print.
Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases.
Buch MH, Mallat Z, Dweck MR, Tarkin JM, O'Regan DP, Ferreira V, Youngstein T, Plein S.
Nat Rev Rheumatol. 2024 Oct;20(10):614-634. doi: 10.1038/s41584-024-01149-x. Epub 2024 Sep 2.
[Malignant rheumatoid arthritis].
Aikawa T.
Nihon Rinsho. 1994 Aug;52(8):2103-8.
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events.
Fa'ak F, Buni M, Falohun A, Lu H, Song J, Johnson DH, Zobniw CM, Trinh VA, Awiwi MO, Tahon NH, Elsayes KM, Ludford K, Montazari EJ, Chernis J, Dimitrova M, Sandigursky S, Sparks JA, Abu-Shawer O, Rahma O, Thanarajasingam U, Zeman AM, Talukder R, Singh N, Chung SH, Grivas P, Daher M, Abudayyeh A, Osman I, Weber J, Tayar JH, Suarez-Almazor ME, Abdel-Wahab N, Diab A.
J Immunother Cancer. 2023 Jun;11(6):e006814. doi: 10.1136/jitc-2023-006814.
Rheumatoid arthritis: mapping the future.
Prasad SK, Vassiliou VS.
JACC Cardiovasc Imaging. 2015 May;8(5):537-539. doi: 10.1016/j.jcmg.2014.12.024.
Mortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: a retrospective, comparative, cohort study.
McCarter KR, Wolfgang T, Arabelovic S, Wang X, Yoshida K, Banasiak EP, Qian G, Kowalski EN, Vanni KMM, LeBoeuf NR, Buchbinder EI, Gedmintas L, MacFarlane LA, Rao DA, Shadick NA, Gravallese EM, Sparks JA.
Lancet Rheumatol. 2023 May;5(5):e274-e283. doi: 10.1016/s2665-9913(23)00064-4. Epub 2023 Mar 27.
Rheumatic fever.
Rullan E, Sigal LH.
Curr Rheumatol Rep. 2001 Oct;3(5):445-52. doi: 10.1007/s11926-996-0016-4.
